Daré Bioscience, Inc.

NASDAQ:DARE

4.16 (USD) • At close November 1, 2024
Bedrijfsnaam Daré Bioscience, Inc.
Symbool DARE
Munteenheid USD
Prijs 4.16
Beurswaarde 35,552,858
Dividendpercentage 0%
52-weken bereik 3.05 - 7.56
Industrie Biotechnology
Sector Healthcare
CEO Ms. Sabrina Martucci Johnson
Website https://www.darebioscience.com

An error occurred while fetching data.

Over Daré Bioscience, Inc.

Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing, and marketing products for women's health in the United States. It develops therapies in the areas of contraception, fertility, and sexual and vaginal health. The company's product includes XACIATO, a single-dose vaginal gel prescription product for the treatment

Vergelijkbare Aandelen

Elevation Oncology, Inc. logo

Elevation Oncology, Inc.

ELEV

0.536 USD

Evelo Biosciences, Inc. logo

Evelo Biosciences, Inc.

EVLO

0 USD

MyMD Pharmaceuticals, Inc. logo

MyMD Pharmaceuticals, Inc.

MYMD

1.81 USD

NRx Pharmaceuticals, Inc. logo

NRx Pharmaceuticals, Inc.

NRXP

1.385 USD

Passage Bio, Inc. logo

Passage Bio, Inc.

PASG

0.629 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)